Indiana, US-based biopharma bigwig Eli Lilly has doubled its investment to a total of $2 billion at its Limerick, Ireland manufacturing site. The expansion will increase production of biologic active ...

Martin Smith, PhD CTO, Pall Corporation Thank you for taking the time to view our supplement, which has been driven by our desire to share actionable knowledge in a convenient format as well as to act ...

The firms will co-commercialize the products globally, except for MK-6070 in Japan where Merck (known as MSD outside of the US and Canada) will retain the exclusive rights. Merck will also be solely ...

We at BPI had so much fun putting together our big anniversary retrospective issue last year that we decided to make it an annual tradition starting this year — albeit on a bit smaller scale. There’s ...

This special summer issue serves as an “expression platform” for as many different industry voices as we could squeeze in between our front and back covers. To get even more points of view than our ...

Jared Auclair, Director, ICH Q1 Stability Training Center, Biopharmaceutical Analysis & Training Lab (BATL) and Adjunct Professor, Northeastern University and NIBRT (Worcester, MA) ...

Happy 2022 to all of BPI’s loyal and supportive authors, readers, and advertisers. Despite continuing pandemic impediments, your industry continues to show remarkable flexibility and resilience. As ...